DYNAMIKA: Simplifying Central Imaging Review 

DYNAMIKA is IAG’s enterprise-scale, cloud-based platform for imaging processing and data management, designed for multi-centre trial settings. The comprehensive software system enables:  

  • Central imaging quality control
  • Streamlined trial progress 
  • Central reads 
  • Integration with AI tools for faster read-outs and decision support 


Key features include: 

  • User access control 
  • Site data uploading 
  • Quality control 
  • Data preparation for reading 
  • Range of industry-standard reading protocols 
  • Data export 
  • Study progress reporting 


DYNAMIKA has powered numerous global clinical studies, from Phase I-IV, managing most modalities in key therapeutic areas. Over the past decade, we engaged with sites around the world, processing complex imaging data from thousands of patients. 

Control of Imaging Data Workflow  

DYNAMIKA’s cloud-based architecture ensures rapid speed of trial start-up, site qualification and initiation. It can be used in any size trial and typically requires no additional hardware or software download for sites or image readers 

By connecting multiple stakeholders, e.g. sites, readers, investigators and project managers, we enable them to acquire, transfer and manage imaging data through the secure cloud infrastructure, share and query the data points and communicate with the trial team within the platform, manage performance of all stakeholders on the trial, conduct real-time data quality control and lock a database quickly after the last patient visit. 

Central Image Review   

Once the images are uploaded on a cloud, personally identifiable data removed and controlled for quality, the same platform is used to score the images. DYNAMIKA incorporates many state-of-the-art radiological scoring systems. . Read about scoring systems and imaging in Your Therapeutic Area of focus. 

You will be deploying the proven methods for image review in your trial, which support earlier read-outs, robust go / no-go decisions, and objective assessment of patient responses. 

We work with your team to to bring the most comprehensive set of scoring systems and quantitative imaging biomarkers within DYNAMIKA to allow capturing the efficacy of a novel treatment with the highest degree of accuracy. 

On Time, on Budget, with no Quality Compromise  

Automation of labour intensive steps, such audit trail, de-identification, tracking, read adjudication saves time. Advanced built-in functionality for patient movement correction and inter-scan alignment increases reproducibility of the results and accuracy of the reading. 

Planning a trial and would like to learn more about IAG and DYNAMIKA?

Email: imaging.experts@ia-grp.com

IAG, Image Analysis Group
Leading imaging Clinical Research Organization that combines medical and operational expertise with cutting-edge proprietary A.I. capabilities to power drug development, and to deliver the potential for companion diagnostic tool. IAG has been serving biotech and pharma clients globally since 2007, reliably supporting all aspects of phase I to III imaging trials across multiple indications.
Our team helps to optimise imaging studies by leveraging our in-house radiology expertise in the design and execution of trials, and through our cutting-edge Dynamika platform, which allows for effective imaging data management and accelerated patient recruitment. With a pioneering proven innovation strategy, we enhance the value and market potential of novel therapeutic assets, as demonstrated through successful pharmaceutical partnerships.
Global Client Services: Clinical Trials
At IAG, we strategically use imaging, such as MRI, CT, and PET to accelerate drug development and lower investment risks into R&D. Whether you are entering a phase I-III and need early robust efficacy data or planning an A.I. powered innovation project, our science, operations, and technology teams will work with you to develop the right solution.
Our Publications

Since 2007, many articles were published to cover scientific discoveries, technology break-throughs and special cases. We list some critically important papers and abstracts.